Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

ADVM holding history

Adverum Biotechnologies, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ADVM by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−234,541−100.0%Sold outHolders
Q3 2025234,541$1.06M<0.1%−51,509−18.0%ReducedHolders
Q2 2025286,050$615.2K<0.1%−1,744−0.6%ReducedHolders
Q1 2025287,794$1.26M<0.1%−23,211−7.5%ReducedHolders
Q4 2024311,005$1.45M<0.1%+104,262+50.4%AddedHolders
Q3 2024206,743$1.45M<0.1%−16,684−7.5%ReducedHolders
Q2 2024223,427$1.53M<0.1%+196,884+741.8%AddedHolders
Q1 202426,543$375.3K<0.1%+7,684+40.7%AddedConverted for a 1-for-10 splitHolders
Q4 2023188,595$142.0K<0.1%−103,875−35.5%ReducedHolders
Q3 2023292,470$439.0K<0.1%+108,348+58.8%AddedHolders
Q2 2023184,122$292.8K<0.1%−240.0%ReducedHolders
Q1 2023184,146$132.1K<0.1%−16,828−8.4%ReducedHolders
Q4 2022200,974$117.0K<0.1%−75,135−27.2%ReducedHolders
Q3 2022276,109$262.0K<0.1%−47,037−14.6%ReducedHolders
Q2 2022323,146$387.0K<0.1%−270,473−45.6%ReducedHolders
Q1 2022593,619$778.0K<0.1%−93,511−13.6%ReducedHolders
Q4 2021687,130$1.21M<0.1%−60,199−8.1%ReducedHolders
Q3 2021747,329$1.62M<0.1%−532,481−41.6%ReducedHolders
Q2 20211,279,810$4.48M<0.1%−118,628−8.5%ReducedHolders
Q1 20211,398,438$13.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.